QDEL (QuidelOrtho) GF Value : $59.16 (As of Apr. 05, 2025)

View and export this data going back to 1992. Start your Free Trial

What is QuidelOrtho GF Value?

As of today (2025-04-05), QuidelOrtho's share price is $28.08. QuidelOrtho's GF Value is $59.16. Therefore, QuidelOrtho's Price-to-GF-Value for today is 0.47. Based on the relationship between the current stock price and the GF Value, GuruFocus believes QuidelOrtho is Possible Value Trap, Think Twice.

The GF Value represents the intrinsic value of a stock, determined using GuruFocus' proprietary methodology. The GF Value Line on our stock Summary page provides an estimate of the stock’s fair-trading value.

To calculate this value, GuruFocus follows these steps:

We analyze historical correlations between the stock price and key business performance metrics, such as revenue, earnings, cash flow, and book value.
We identify the metrics that have the strongest historical correlation with the stock price and determine the historical multiples at which the stock has traded relative to these metrics.
Using these historical multiples as a reference, we estimate the stock's fair value while accounting for future business growth. Adjustments may be made based on the company’s past returns and growth trends.

GuruFocus believes that the GF Value Line represents the fair value at which a stock should trade. Stock prices typically fluctuate around this line. If a stock’s price is significantly above the GF Value Line, it is considered overvalued, and its future returns are likely to be lower. Conversely, if the stock price is significantly below the GF Value Line, its future returns are likely to be higher.

Please note that "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

QuidelOrtho (NAS:QDEL) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 ratings:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" applies to companies that appear significantly undervalued but are either experiencing a long-term business decline or facing financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) A sufficient margin of safety exists only when the stock is undervalued.

QuidelOrtho's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	28.08	/	59.16
	=	0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho GF Value Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

QuidelOrtho Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (NAS:QDEL) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

0A55:UK

Address

9975 Summers Ridge Road, San Diego, CA, USA, 92121

Website

https://www.quidelortho.com

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Executives

Carlyle Group Inc.	10 percent owner	C/O THE CARLYLE GROUP, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Joseph M Busky	officer: Chief Financial Officer	1717 DEERFIELD ROAD, DEERFIELD IL 60015
Louise Brandy	officer: SVP, Chief Information Officer	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Patrick Klein	officer: Chief Administrative Officer	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Tc Group Vi Cayman, L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Christopher M Smith	director	125 CONSTITUTION DRIVE, MENLO PARK CA 94025
Douglas C Bryant	director, officer: Chairman & CEO	C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Michelle A. Hodges	officer: SVP, General Counsel	9975 SUMMERS RIDGE ROAD, SAN DIEGO CA 92121
Wilkins Joseph D Jr.	director	82414 PUCCINI DRIVE, INDIO CA 92203
Robert Joseph Bujarski	officer: See Remarks	C/O QUIDEL CORPORATION, 12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130
Stephen H. Wise	director	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Tamara A. Ranalli	officer: SVP, Molecular Bus. Unit	9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Robert R. Schmidt	director	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004
Kenneth F Buechler	director
Werner Kroll	officer: SVP, Research and Development	12544 HIGH BLUFF DRIVE, SUITE 200, SAN DIEGO CA 92130